Anthera Pharmaceuticals (OTCMKTS:ANTH) Share Price Crosses Above 200-Day Moving Average – Time to Sell?

Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH) crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $0.00 and traded as high as $0.0001. Anthera Pharmaceuticals shares last traded at $0.0001, with a volume of 662 shares.

Anthera Pharmaceuticals Price Performance

About Anthera Pharmaceuticals

Anthera Pharmaceuticals was a U.S.-based biopharmaceutical company focused on developing therapies for serious inflammatory, autoimmune and gastrointestinal diseases. The company operated primarily as a clinical-stage drug developer and did not establish a broad commercial product portfolio.

Its principal programs included varespladib, an investigational treatment intended to address inflammatory conditions, and Sollpura (liprotamase), an oral pancreatic enzyme replacement therapy for people with exocrine pancreatic insufficiency.